Grant ID

97-RC-324-1

Illness

Schizophrenia

Primary Drug/Intervention

Famciclovir

Primary Dosage

N/A

Secondary Drug Intervention

Olanzapine

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Brusov

Sample Size

60

Duration of Study Period for Each Subject

N/A

Outcome Measurements

N/A

Results

Sixty patients with schizophrenia were randomized to receive olanzapine, olanzapine plus placebo, or olanzapine plys famciclovir for 28 weeks. The three groups showed no significant differences with regard to PANSS ratings.

Publication

N/A

Link

N/A

PI Name

Oleg Brusov

Degree

PhD

Center

Russian Academy of Research

Institution

N/A

Address

City or Town

Moscow

State or Province

N/A

Zip or Postal Code

N/A

Country

Russia

Email Address

N/A